Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


Your body is 3D, why is your cell culture not?

27 Sep 2013 - 27 Sep 2013 - Webinar



Bookmark and Share


3D cell-based applications close the gap between conventional in-vitro approaches and in vivo animal model research. By automating the 3D cell culture process and assay detection in a microplate based format, this significantly shortens development time of new drug candidates as well as offering more reliable statistical results.   

Tecan will present solutions for 3D cell culture systems using the Alvetex (Reinnervate), RAFT (TAP Biosystems)  scaffold based, and GravityPlus (InSphero) scaffold-free technology. In particular, automating a 3D cell culture system with the Freedom EVO® liquid handling platform offers a simple and reliable approach for cultivation, and the Infinite M-200 PRO multi-detection reader with its Optimal Read function in conjunction with the patent pending Gas Control Module (GCMTM) offers an excellent solution for acute and chronic toxicity tests, as well as multiplexed assays in cancer research.

Presenter:
Christian Oberdanner, PhD
Application Specialist Sales & Marketing, Tecan Austria GmbH

Christian Oberdanner, PhD, studied Molecular- and Cell-Biology at the University of Salzburg, Austria. In his doctoral thesis he focused on Reactive Oxygen Species-mediated apoptosis induction in photodynamic cancer therapy. 

Christian started to work for Tecan Austria as an external scientific consultant already during his last year at University. After his graduation he joined Tecan as Application Specialist in the department for research and development but quickly changed to the sales and marketing department. His expertise is on applications for Tecan’s multimode readers and microplate washers but he is also contributing to new product developments as a Junior Product Manager.


Further information
Scientific News
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!